Outcome after implantation of a novel prosthetic anal sphincter in humans

The British Journal of Surgery
I G FinlayC A Hajivassiliou

Abstract

A novel prosthetic anal sphincter (PAS) has been developed that aims to occlude by flattening and angulating the bowel, reproducing the action of the puborectalis muscle. The safety of the PAS has been confirmed in biomechanical, in vitro and long-term animal survival studies. The Medical Devices Agency approved implantation in 12 patients. The PAS was placed in the pelvis around the anorectal junction via a transabdominal approach in 12 patients with severe faecal incontinence. The device was activated 6 weeks after surgery. Fibreoptic examination of the mucosa below the device was undertaken at various intervals during review. At a median follow-up of 59 (range 30-72) months nine of the 12 patients had a functioning PAS. There were no device-related infective complications after the initial operation but one patient developed pseudomembranous colitis and had the device removed. The PAS was effective in restoring continence in ten of 11 patients. Median (range) Cleveland Clinic continence scores improved from 16 (7-20) before to 3 (0-7) after surgery. In two patients the PAS was eventually removed owing to infection after revisional surgery. There was no clinical or histological evidence of gastrointestinal mucosal ischaemia. ...Continue Reading

References

Nov 9, 1991·Lancet·N S WilliamsE S Watkins
Aug 1, 1987·Lancet·J Christiansen, M Lorentzen
Mar 1, 1989·The Journal of Surgical Research·R M Satava, G E King
Sep 11, 1993·BMJ : British Medical Journal·M Swash
Jan 1, 1993·Diseases of the Colon and Rectum·J M Jorge, S D Wexner
Jan 1, 1996·The British Journal of Surgery·C A HajivassiliouI G Finlay
Dec 1, 1996·Diseases of the Colon and Rectum·W D WongD A Rothenberger
Dec 1, 1996·Diseases of the Colon and Rectum·P A LehurJ M Buzelin
Jun 1, 1997·Diseases of the Colon and Rectum·C A HajivassiliouI G Finlay
May 1, 1997·Journal of Medical Engineering & Technology·C A HajivassiliouI G Finlay
Feb 14, 1998·The British Journal of Surgery·C A HajivassiliouI G Finlay
Jan 6, 1999·The British Journal of Surgery·C A Hajivassiliou, I G Finlay
Feb 23, 1999·The British Journal of Surgery·G PinedoM A Kamm
May 3, 2000·The British Journal of Surgery·G SavoyeF Michot
Jul 6, 2000·Lancet·A J MaloufR J Nicholls
May 15, 2002·Diseases of the Colon and Rectum·Paul-Antoine LehurStanislas Bruley des Varannes

❮ Previous
Next ❯

Citations

Aug 10, 2006·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·O RuthmannH J Schrag
Aug 13, 2005·Langenbeck's Archives of Surgery·Christophe MüllerWaldemar Uhl
Apr 22, 2011·Artificial Organs·Zong-Hai HuangXin-Jun Han
Nov 28, 2013·Nature Reviews. Gastroenterology & Hepatology·Peter J Mitchell, Peter M Sagar
Oct 12, 2007·International Journal of Colorectal Disease·Jarno MelenhorstCor G Baeten
May 28, 2013·Journal of Medical Engineering & Technology·Peng ZanEnyu Jiang
Jul 31, 2013·Journal of the American College of Surgeons·Kwang Dae HongSteven D Wexner
Mar 2, 2016·Annals of Biomedical Engineering·Elisa FattoriniBert Müller
Aug 4, 2009·Best Practice & Research. Clinical Gastroenterology·B GovaertC G M I Baeten
Sep 15, 2015·Journal of Zhejiang University. Science. B·Ming-hui WangYun Luo
May 6, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·UNKNOWN Italian Society of Colorectal Surgery (SICCR)Paolo Usai Satta
Nov 28, 2018·Artificial Organs·Zerun ZhouFangfang Hua
Jul 12, 2014·Journal of Clinical Gastroenterology·Satish S C Rao
Jan 14, 2020·The International Journal of Artificial Organs·Zerun ZhouFangfang Hua
Apr 20, 2014·The International Journal of Artificial Organs·Lei KeZai-Xian Ding
Jul 19, 2017·Artificial Organs·Wentian JinZerun Zhou
Dec 24, 2013·The International Journal of Artificial Organs·Yongbing WangGuozheng Yan
Dec 24, 2013·The International Journal of Artificial Organs·Jelka Masin-SpasovskaGoce Spasovski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.